| Income Statement | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-09-30 |
|---|---|---|---|---|
| Loss from operations | -60,138 | -46,478 | -44,636 | -50,522 |
| Interest income | 2,681 | 3,081 | 2,996 | 3,422 |
| Net loss | -57,457 | -43,397 | -41,640 | -47,100 |
| Earnings per share, basic | -0.65 | -0.5 | -0.52 | -0.78 |
| Earnings per share, diluted | -0.65 | -0.5 | -0.52 | -0.78 |
| Weighted average number of shares outstanding, basic | 87,957,868 | 87,010,742 | 79,410,354 | 60,205,327 |
| Weighted average number of shares outstanding, diluted | 87,957,868 | 87,010,742 | 79,410,354 | 60,205,327 |
Immunome Inc. (IMNM)
Immunome Inc. (IMNM)